Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (Q88486711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

title

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

Middle East respiratory syndrome coronavirus

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

Stephanie A Montgomery

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

Darius Babusis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

Mark R. Denison

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

17

Robert Jordan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

14

Danielle Porter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

19

Ralph S Baric

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

16

Tomas Cihlar

1 reference

30 April 2020

3

Sarah R Leist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

6

Ariane J Brown

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

4

Alexandra Schäfer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

2

Amy C Sims

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

10

Michael O Clarke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

11

Jamie E Spahn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

15

Joy Y Feng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

author name string

John Won

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

Alison Hogg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

Laura Bauer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

Scott Sellers

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

publication date

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

SARS and MERS: recent insights into emerging coronaviruses

30 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Correction: MERS-CoV spillover at the camel-human interface.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Serial Histopathological Examination of the Lungs of Mice Infected with Influenza A Virus PR8 Strain

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

New Metrics for Evaluating Viral Respiratory Pathogenesis

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Molecular diversity of coronaviruses in bats.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Coronaviruses - drug discovery and therapeutic options.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Clinical uses of interferons

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Virus interference. I. The interferon

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Coupling of Airway Smooth Muscle Bitter Taste Receptors to Intracellular Signaling and Relaxation Is via Gαi1,2,3.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Viral Load Kinetics of MERS Coronavirus Infection

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

A simple practice guide for dose conversion between animals and human

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038/S41467-019-13940-6

7 January 2021

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

1 reference

12 December 2020

The Superiority of IFN-λ as a Therapeutic Candidate to Control Acute Influenza Viral Lung Infection

1 reference

12 December 2020

MERS-CoV spillover at the camel-human interface

1 reference

12 December 2020

Caspase-3 Mediated Cell Death in the Normal Development of the Mammalian Cerebellum

1 reference

12 December 2020

10.1038/S41467-019-13940-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 April 2020

ADS bibcode

2020NatCo..11..222S

0 references

1124005183

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31924756 AND SRC:MED&resulttype=core&format=json

30 April 2020

PubMed publication ID

31924756

1 reference